Review

Targeting composite treatment of type 2 diabetes in middle-income countries – walking a tightrope between hyperglycaemia and the dangers of hypoglycaemia

Jeffrey Wing, Daksha Jivan

Abstract


Middle-income countries need a rational and cost-effective approach to optimise management of type 2 diabetes mellitus (T2DM). There is a paucity of data from such countries on the extent of hypoglycaemia and its consequences for their healthcare systems. This review provides the context for health policy change and evaluates available data on diabetes complications, focusing on hypoglycaemia in T2DM patients in non-Western countries. Suitable guidelines are suggested for these communities, which are in transition from poverty to affluence and in transition from an environment where infectious diseases predominate to one where non-communicable diseases are predominant. 


Authors' affiliations

Jeffrey Wing, Division of Endocrinology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Donald Gordon Medical Centre, Johannesburg, South Africa

Daksha Jivan, Division of Endocrinology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Full Text

PDF (187KB)

Keywords

Medicine; Endocrinology; Type 2 diabetes; Hypoglycaemia; Middle-income countries; Hyperglycaemia

Cite this article

South African Medical Journal 2016;106(1):57-61. DOI:10.7196/SAMJ.2016.v106i1.10284

Article History

Date submitted: 2015-11-04
Date published: 2015-12-16

Article Views

Abstract views: 1984
Full text views: 1013

Comments on this article

*Read our policy for posting comments here